Tyra Biosciences Advances First-in-Human TYRA-430 Trial in FGFR-Driven Liver and Solid Tumors
at www.tipranks.com (Wed, 29-Jul 12:31 PM)
Tyra Biosciences Advances TYRA-200 Into First-in-Human FGFR2 Cancer Trial
at www.tipranks.com (Wed, 29-Jul 12:31 PM)
TYRA’s $383.5 Million Cash Position and Multiple Phase 2 Milestones Set Stage for Major Advances
Market Chameleon (Thu, 14-May 11:42 AM)
